19 July 2021 · Global Partnership for Zero Leprosy

Leprosy Diagnostic Working Group develops 2 target product profiles

Despite available treatment, over 200,000 individuals were diagnosed with leprosy across more than 120 countries in 2019. Early detection of the disease can help prevent disability and the spread of infection. Detection rates could be improved with a tool that’s easy to use to accurately … Read More >

2 March 2021 · NLR International

New NLR study predicts 90% leprosy reduction through preventive treatment of 40 million people in 22 years

To interrupt leprosy transmission and reduce annual new cases significantly, contact tracing and preventive treatment needs to be implemented in all leprosy-endemic countries Amsterdam, the Netherlands, March 1, 2021 – New research by NLR, until No Leprosy Remains (NLR) and Erasmus University MC, published in PLOS Neglected Tropical … Read More >

6 January 2021 · ILEP Technical Commission

Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP)

Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP), in light of recent  information on nitrosamine impurities in rifampicin  A number of different problems have affected the supply of rifampicin and MDT to countries this year. The most recent of these has been … Read More >

4 November 2020 · Global Partnership for Zero Leprosy

A Prioritized Zero Leprosy Research Agenda

The Global Partnership for Zero Leprosy (GPZL) presented the prioritised Zero Leprosy Research Agenda at the WHO Global Consultation on Global Leprosy Strategy 2021 – 2030 last week. In 2018, the Research Agenda working group’s eight different sub-groups conducted a series of discussions on research … Read More >

2 November 2020 · Novartis International AG

Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests

Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is generally well accepted by patients, … Read More >

26 February 2020 · Global Partnership for Zero Leprosy

Project to End Child Leprosy Among Top 100 Proposals for MacArthur $100 Million Grant

The John D. and Catherine T. MacArthur Foundation announced today that ‘End Child Leprosy by 2030: Break Transmission and Eliminate Stigma’ was one of the highest-scoring proposals, designated as the Top 100, in its 100&Change competition for a single $100 million grant to help solve one of the world’s most critical social challenges.

11 November 2019 · Global Partnership for Zero Leprosy

Workshop explores how to scale up PEP and advance research

Leprosy Research Initiative (LRI), NLR, and the Global Partnership for Zero Leprosy (GPZL) co-hosted a workshop in Amsterdam in November 2019 to discuss issues related to post-exposure prophylaxis (PEP).

20 August 2018 · World Health Organization

Guidelines for the diagnosis, treatment and prevention of leprosy

WHO’s Global Leprosy Programme has released the full Guidelines for the diagnosis, treatment and prevention of leprosy. The Guidelines provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in low and middle-income countries. The target audience of this … Read More >